Antiplatelet therapy prior to COVID-19 infection impacts on patients mortality: a propensity score-matched cohort study

Antiplatelet therapy prior to COVID-19 infection impacts on patients mortality: a propensity score-matched cohort study

Abstract One of the major pathomechanisms of COVID-19 is the interplay of hyperinflammation and disruptions in coagulation processes, involving thrombocytes. Antiplatelet therapy (AP) by anti-inflammatory effect and inhibition of platelet aggregation may affect these pathways. The aim of this study...

Full description

Bibliographic Details
Main Authors: Mateusz Sokolski, Konrad Reszka, Barbara Adamik, Katarzyna Kilis-Pstrusinska, Weronika Lis, Michał Pomorski, Janusz Sokolowski, Adrian Doroszko, Katarzyna Madziarska, Ewa Anita Jankowska, Marcin Protasiewicz
Format: Article
Language:English
Published: Nature Portfolio 2024-02-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-55407-9

Internet

https://doi.org/10.1038/s41598-024-55407-9

Similar Items